The green light for the pre-filled, single-use pen version of Tezspire (tezepelumab ... such as Sanofi/Regeneron's IL-4/IL-13 inhibitor Dupixent (dupilumab) and AZ's IL-5 inhibitor Fasenra ...

Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the ...

Also: Best digital notebooks of 2025 Drawing tablets come in two main forms: pen displays, which feature built-in screens for immersive experiences, and pen tablets. These require an external ...